After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
This page covers the main factors that move indices, including earnings, policy, and macro conditions, with tips for interpreting changes.
28,500 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
Starting with almost nothing, one investor grew a portfolio of 11 real estate deals in six years. Learn the step-by-s...
As markets shift, investors wonder if the Vanguard Total International Stock ETF is a smarter pick today than a month...
Space investors woke up to news that spacex stock sank today, reflecting a mix of macro pressures and company-specifi...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...